Working… Menu
Trial record 1 of 1 for:    NCT03267173
Previous Study | Return to List | Next Study

Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03267173
Recruitment Status : Unknown
Verified August 2017 by First Affiliated Hospital of Harbin Medical University.
Recruitment status was:  Recruiting
First Posted : August 30, 2017
Last Update Posted : August 30, 2017
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Information provided by (Responsible Party):
First Affiliated Hospital of Harbin Medical University

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : June 2019